Cancer Vaccine Study Offers Hope for Patients With Lynch Syndrome
NOUS-209 study shows strong immune response in participants.
This article is for subscribers only.
Hi, it’s Jason in Melbourne. Cancer vaccines usually arrive after bad news, once tumors have already taken hold. A new study asks whether immunity itself can get in first, training the body to head off disease before it ever forms. More on that in a moment, but first …
For people born with Lynch syndrome, cancer risk isn’t hypothetical. The inherited condition, found in about 1 in 280 people, sharply increases the odds of developing colorectal, endometrial and several other cancers, often at younger ages.